Z. Halime et al. / Tetrahedron 62 (2006) 3056–3064
3061
(ESC) Calcd for C62H62N8O10Na (MCNa)C 1101.4486.
Found, 1101.4495. UV–vis (CH2Cl2) l nm (10K33,
dm3 molK1 cmK1): 418 (301.3), 516 (17.1), 551 (5.5), 589
(5.4), 646 (2.6).
8.51 (d, JZ4.5 Hz, 4H, bpyr), 8.34 (d, JZ8 Hz, 2H, aro),
7.86 (d, JZ7.5 Hz, 2H, aro), 7.77 (d, JZ7.5 Hz, 2H, aro),
7.63 (t, JZ8 Hz, 2H, aro), 7.57 (t, JZ7.5 Hz, 2H, aro), 7.27
(m, 2H, aro), 7.24 (s, 4H, aro), 7.19 (s, 4H, aro), 7.14–7.08
(m, 4H, aro), 6.88 (s, 2H, NHCO), 3.60 (br s, 4H, NH2), 2.62
(s, 12H, –CH3), 1.76 (s, 12H, –CH3), 1.58 (s, 8H, –CH2–),
1.38 (m, 8H, –CH2–), 1.29 (s, 12H, –CH3), K1.02 (br s, 8H,
–CH2–), K2.80 (s, 4H, NHpyr). 13C NMR (125 MHz,
CDCl3): dZ158.1, 153.5, 145.3, 139.0, 138.7, 138.2, 136.9,
136.6, 135.2, 130.5, 129.7, 128.4, 124.1, 120.8, 119.7,
119.3, 116.2, 114.0, 71.5, 69.8, 68.8, 50.7, 46.8, 22.5, 22.1,
21.7. HRMS (ESC) Calcd for C114H111N14O6 (MCH)C
1771.8811. Found, 1771.8813. UV–vis (CH2Cl2) l nm
(10K33, dm3 molK1 cmK1): 418 (512.3), 515 (40.3), 547
(19.8), 592 (19.1), 647 (12.5).
4.2.3. 1,4,10,13-Tetraoxa-7,16-diaza-cyclooctadecane-7-
carboxylic acid {2-[a-15-(2-nitro-phenyl)-10,20-bis-
(2,4,6-trimethyl-phenyl)-porphyrin-a-5-yl]-phenyl}-
amide 2aNO2. A mixture of porphyrin 5aNO2aa (31 mg,
41 mmol), triethylamine (11 mL, 82mmol) and carbonic acid
ditrichloromethyl ester (triphosgene) (4 mg, 13.6 mmol) in
dry CH2Cl2 (20 mL) was stirred for 1 h under argon at room
temperature. This mixture was added dropwise, over 2 h
with a syringe pump to a solution of diaza-18-crown-6 ether
(11 mg, 41 mmol) in dry CH2Cl2 (10 mL). The mixture was
stirred for an additional 1 h. The solvent was removed under
vacuum and the residue was purified by chromatography
column. The desired compound 2aNO2 was eluted with 1%
4.2.6. 1,4,10,13-Tetraoxa-7,16-diaza-cyclooctadecane-
7,16-dicarboxylic acid bis-{2-[a-15-(2-amino-phenyl)-
10,20-bis-(3,5-dimethoxy-phenyl)-porphyrin-a-5-yl]-
phenyl}-diamide 3b. 1H NMR (500 MHz, CDCl3): dZ8.87
(d, JZ4.8 Hz, 4H, bpyr), 8.82 (d, JZ4.8 Hz, 4H, bpyr),
8.79 (d, JZ4.8 Hz, 4H, bpyr), 8.65 (d, JZ4.8 Hz, 4H,
bpyr), 8.38 (d, JZ8.1 Hz, 2H, aro), 7.85 (d, JZ7.2 Hz, 2H,
aro), 7.79 (d, JZ7.2 Hz, 2H, aro), 7.68 (t, JZ7 Hz, 2H, aro),
7.62 (t, JZ7.8 Hz, 2H, aro), 7.26 (m, 6H, aro), 7.17 (m, 6H,
aro), 7.08 (d, JZ7.8 Hz, 2H, aro), 6.87 (br s, 4H, aro), 6.78
(br s, 2H, NHCO), 3.93 (s, 12H, –OCH3), 3.90 (s, 12H,
–OCH3), 3.53 (br s, 4H, NH2), 1.82 (br s, 8H, –CH2–), 1.13
(br s, 8H, –CH2–), K0.46 (br s, 8H, –CH2–), K2.93 (s, 4H,
NHpyr). 13C NMR (125 MHz, CDCl3): dZ158.8, 146.8,
140.5, 134.9, 130.7, 129.9, 120.7, 119.3, 117.5, 114.3,
113.7, 99.9, 68.4, 67.5, 55.6, 48.9. HRMS (ESC) Calcd for
C110H102N14O14Na (MCNa)C 1865.7598. Found,
1865.7577. UV–vis (CH2Cl2) l nm (10K33, dm3 molK1
cmK1): 418 (523.5), 514 (33.4), 549 (9.6), 589 (10.2),
645 (4.7).
1
methanol/CH2Cl2 and obtained in 88% yield (38 mg). H
NMR (500 MHz, CDCl3): dZ8.83 (d, JZ4.5 Hz, 2H,
bpyr), 8.69–8.62 (m, 4H, bpyr and 1H, aro), 8.59 (d, JZ
4.5 Hz, 2H, bpyr), 8.43 (dd, J1Z8 Hz, J2Z1.5 Hz, 1H, aro),
8.23 (dd, J1Z7 Hz, J2Z1.5 Hz, 1H, aro), 7.99–7.92 (m, 3H,
aro), 7.74 (td, J1Z8 Hz, J2Z1.5 Hz, 1H, aro), 7.69 (s, 1H,
NHCO), 7.34 (td, J1Z7.5 Hz, J2Z1 Hz, 1H, aro), 7.30 (s,
2H, aro), 7.28 (s, 2H, aro), 5.00 (br s, 1H, NH), 2.88 (br s,
4H, –CH2–), 2.63 (s, 6H, –CH3), 2.38 (br s, 12H, –CH2–),
1.97 (br s, 8H, –CH2–), 1.85 (s, 6H, –CH3), 1.82 (s, 6H,
–CH3), K2.51 (s, 2H, NHpyr). 13C NMR (125 MHz,
CDCl3): dZ157.3, 152.2, 141.6, 139.7, 139.2, 138.5,
138.2, 137.4, 136.6, 135.5, 131.5, 130.1, 129.9, 129.8,
128.4, 128.3, 124.3, 120.8, 119.4, 119.2, 116.0, 114.0, 71.5,
69.8, 68.7, 49.1, 47.0, 22.2, 22.0, 21.9. HRMS (ESC) Calcd
for C63H67N8O7 (MCH)C 1047.5132. Found, 1047.5131.
UV–vis (CH2Cl2) l nm (10K33, dm3 molK1 cmK1): 420
(261.8), 516 (15.6), 549 (5.4), 592 (4.9), 648 (2.6).
4.2.4. 1,4,10,13-Tetraoxa-7,16-diaza-cyclooctadecane-7-
carboxylic acid {2-[a-15-(2-amino-phenyl)-10,20-bis-
(3,5-dimethoxy-phenyl)-porphyrin-a-5-yl]-phenyl}-
4.2.7. 1,3-Bis-{2-[1,4,10,13-tetraoxa-7,16-diaza-cyclo-
octadecane-7,16-dicarboxylic acid bis-{2-[2-{10,20-bis-
(3,5-dimethoxy-phenyl)}-a-15-phenyl]-amide}-porphy-
1
1
amide 2b. H NMR (500 MHz, CDCl3): dZ9.06 (d, JZ
rin-a-5,50-diyl]-diphenyl}-urea 4b. H NMR (500 MHz,
4.5 Hz, 2H, bpyr), 9.04 (d, JZ4.5 Hz, 2H, bpyr), 8.98 (d,
JZ5 Hz, 2H, bpyr), 8.93 (d, JZ5 Hz, 2H, bpyr), 8.59 (d,
JZ9 Hz, 1H, aro), 7.99 (d, JZ7.5 Hz, 1H, aro), 7.87 (d, JZ
7.5 Hz, 1H, aro), 7.78 (t, JZ6.5 Hz, 1H, aro), 7.64 (t, JZ
7.5 Hz, 1H, aro), 7.38 (m, 5H, aro), 7.19 (m, 3H, aro and
NHCO), 6.93 (t, JZ2.5 Hz, 2H, aro), 4.03 (s, 6H, –OCH3),
4.01 (s, 1H, NH), 3.97 (s, 6H, –OCH3), 2.68 (br s, 4H,
–CH2–), 2.52 (br s, 4H, –CH2–), 2.36 (br s, 4H, –CH2–),
1.96 (br s, 4H, –CH2–), 1.61 (br s, 4H, –CH2–), 1.43 (br s,
4H, –CH2–), K2.75 (s, 2H, NHpyr). 13C NMR (125 MHz,
CDCl3): dZ159.1, 150.2, 140.6, 134.9, 131.6, 129.7, 121.0,
119.8, 117.7, 114.6, 113.7, 111.5, 99.9, 95.9, 70.3, 68.4,
64.1, 55.6, 48.5, 46.6. HRMS (ESC) Calcd for C61H65N8O9
(MCH)C 1053.4874. Found, 1053.4867. UV–vis (CH2Cl2)
l nm (10K33, dm3 molK1 cmK1): 419 (215.3), 512 (14.7),
548 (4.3), 588 (4.4), 646 (2.3).
CDCl3): dZ8.73 (d, JZ4.2 Hz, 4H, bpyr), 8.67 (d, JZ
5.1 Hz, 4H, bpyr), 8.65 (d, JZ5.1 Hz, 4H, bpyr), 8.60 (d,
JZ4.2 Hz, 4H, bpyr), 8.51 (d, JZ8.2 Hz, 2H, aro), 8.43 (d,
JZ8.2 Hz, 2H, aro), 7.84 (t, JZ8.4 Hz, 2H, aro), 7.71 (m,
4H, aro), 7.61 (d, JZ7.5 Hz, 2H, aro), 7.40 (t, JZ7.5 Hz,
2H, aro), 7.30 (t, JZ7.5 Hz, 2H, aro), 7.16 (s, 4H, aro), 6.98
(s, 4H, aro), 6.81 (s, 4H, aro), 6.77 (s, 2H, NHCO), 5.69 (s,
2H, NHCO), 3.87 (s, 12H, –OCH3), 3.78 (s, 12H, –OCH3),
3.80 (br s, 8H, –CH2–), 2.15 (br s, 8H, –CH2–), 0.89 (br s,
8H, –CH2–), K3.25 (s, 2H, NHpyr). 13C NMR (125 MHz,
CDCl3): dZ158.9, 140.0, 139.3, 129.6, 129.2, 128.1, 127.5,
126.2, 125.4, 124.6, 121.2, 115.2, 105.5, 55.8, 52.8, 29.7.
HRMS (ESC) Calcd for C111H100N14O15Na (MCNa)C
1891.7390. Found, 1891.7372. UV–vis (CH2Cl2) l nm
(10K33, dm3 molK1 cmK1): 422 (435.5), 515 (24.4), 550
(8.7), 589 (8.8), 646 (4.7).
4.2.5. 1,4,10,13-Tetraoxa-7,16-diaza-cyclooctadecane-
7,16-dicarboxylic acid bis-{2-[a-15-(2-amino-phenyl)-
10,20-bis-(2,4,6-trimethyl-phenyl)-porphyrin-a-5-yl]-
phenyl}-diamide 3a. 1H NMR (500 MHz, CDCl3): dZ8.76
(d, JZ4.5 Hz, 4H, bpyr), 8.59 (d, JZ4.5 Hz, 8H, bpyr),
4.2.8. a-5,15-Bis-(2-aminophenyl)-10,20-bis-(2,4,6-tri-
methyl-phenyl)-porphyrin 5aaa and a-5-b-15-(2-amino-
phenyl)-10,20-bis-(2,4,6-trimethyl-phenyl)-porphyrin
5aab. The two atropisomers of 7a (200 mg, 0.25 mmol)
were dissolved in CH2Cl2 (50 mL) in a 250 mL round flask.